APUS Apimeds Pharmaceuticals US, Inc.
7.050USD-1.12%Mkt Cap: 10.64M $P/E: —1d ago
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. op…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
Company
Market Cap10.64M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.00M USD
Revenue/Share—
Last Price7.050 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B10.99
EPS (TTM)-55.97
EPS (Forward)—
52W Range
1.5101% of range403.10
52W High403.10 USD
52W Low1.510 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-3.91%
ROA-3.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.93M USD
CapEx (TTM)57.33K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio—
Quick Ratio—
Book Value/Sh0.65 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 24, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.51M
Float—
Insiders58.70%
Institutions2.83%
Short Interest
Short Ratio0.1d
Short % Float1.28%
Short % Out.0.69%
Shares Short10.35K
Short (prev mo.)14.94K
Technical
SMA 503.986 (+76.8%)
SMA 20012.14 (-41.9%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)7.60M
Avg Vol (10d)16.10M
Technical Indicators
RSI (14)64.0
MACD0.6220
MACD Signal0.1970
MACD Hist.+0.4250
BB Upper7.842 USD
BB Middle3.676 USD
BB Lower-0.4894 USD
BB Width226.63%
ATR (14)1.549 USD
Vol Ratio (20d)2.18x